Why don’t we have a male birth control pill? What is the status of RISUG? Why is Vasalgel being promoted by a nonprofit instead of a pharmaceutical company? What are the attitudes of men and women on the topic of male birth control? These topics were covered in a recent edition of The Current on CBC Radio. Host Anna Maria Tremonti interviewed experts to uncover the answers. Dr. Ronald Weiss, who was a member of the 2002 WHO panel to evaluate RISUG, explained that even though RISUG has been researched for decades, the product cannot be marketed in N. America because the studies were not done to international standards. Dr. Weiss indicated that Vasalgel can begin clinical trials after animal studies are conducted in the US. Tremonti concluded the show with an in depth discussion of whether men would be willing to take contraception and how women might respond.
